Hepatitis C virus associated hepatocellular carcinoma
Authors:
- 1 January 2021
- book chapter
- Published by Elsevier
- Vol. 149, 103-142
Abstract
No abstract availableKeywords
This publication has 208 references indexed in Scilit:
- A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus InfectionPLOS ONE, 2013
- Hepatitis C Virus NS2 Protein Inhibits DNA Damage Pathway by Sequestering p53 to the CytoplasmPLOS ONE, 2013
- Long non-coding RNAs and cancer: a new frontier of translational research?Oncogene, 2012
- Impaired hepatitis B vaccine responses during chronic hepatitis C infection: Involvement of the PD-1 pathway in regulating CD4+ T cell responsesVaccine, 2011
- Complement and viral pathogenesisVirology, 2011
- Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent ReinfectionGastroenterology, 2010
- Hepatitis C virus hijacks host lipid metabolismTrends in Endocrinology & Metabolism, 2010
- Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and productionHepatology, 2008
- Hepatitis C Virus NS5A Protein Down-regulates the Expression of Spindle Gene Aspm through PKR-p38 Signaling PathwayJournal of Biological Chemistry, 2008
- Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis CProceedings of the National Academy of Sciences, 2007